BRAF and neoplasm: Importantly (as mentioned above), we could also detect a BRAF V600E mutation in our IHC-equivocal FFPE sample (no. 2) that contained 30% tumor cells and, as such, did not meet the minimum tissue requirement for the Idylla BRAF mutation testing [60].